Amid Nationwide Shortage, Abbott Nutrition Restarts Infant Formula Production
The company started production of EleCare and other specialty formulas
Abbott Nutrition restarted production on infant formula at its Sturgis, Michigan, plant Saturday after meeting initial requirements set by the Food and Drug Administration (FDA).
The company started production of EleCare and other specialty and metabolic formulas. EleCare products are expected to be released around June 20.
"We're also working hard to fulfill the steps necessary to restart production of Similac and other formulas and will do so as soon as we can," an Abbott spokesperson said. "We understand the urgent need for formula, and our top priority is getting high-quality, safe formula into the hands of families across America."
Please select this link to read the complete article from NBC News.